Contact us

877-469-1TRM
424-208-8866

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)

A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Advanced, Metastatic Breast Cancer LEE011 II Open and Accruing